(Q43188323)

15 November 2017

Low body mass index and sarcopenia associated with dose-limiting toxicity of sorafenib in patients with renal cell carcinoma (English)

1 reference

15 November 2017

1 reference

0 references

2

1 reference

15 November 2017

S Antoun

1

1 reference

15 November 2017

L Birdsell

series ordinal

3

1 reference

15 November 2017

B Escudier

series ordinal

4

1 reference

15 November 2017

M B Sawyer

series ordinal

5

1 reference

15 November 2017

20 January 2010

1 reference

15 November 2017

1 reference

15 November 2017

21

1 reference

15 November 2017

8

1 reference

15 November 2017

1594-1598

1 reference

Sorafenib in advanced clear-cell renal-cell carcinoma

15 November 2017

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDP605

Body composition as an independent determinant of 5-fluorouracil-based chemotherapy toxicity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDP605

Prevalence and clinical implications of sarcopenic obesity in patients with solid tumours of the respiratory and gastrointestinal tracts: a population-based study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDP605

Phase II study to investigate the efficacy, safety, and pharmacokinetics of sorafenib in Japanese patients with advanced renal cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDP605

Impact of body mass index on outcomes and treatment-related toxicity in patients with stage II and III rectal cancer: findings from Intergroup Trial 0114.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDP605

Cardiotoxicity associated with the cancer therapeutic agent sunitinib malate

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDP605

Human body composition: advances in models and methods

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDP605

A practical and precise approach to quantification of body composition in cancer patients using computed tomography images acquired during routine care

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDP605

Factors affecting the pharmacokinetics of CPT-11: the body mass index, age and sex are independent predictors of pharmacokinetic parameters of CPT-11.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDP605

The influence of relative body weight on toxicity of combination chemotherapy with cisplatin and etoposide

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDP605

Sarcopenia as a determinant of chemotherapy toxicity and time to tumor progression in metastatic breast cancer patients receiving capecitabine treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDP605

Sarcopenia is predictive of nosocomial infection in care of the elderly.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDP605

Evaluation of the nutritional and inflammatory status in cancer patients for the risk assessment of severe haematological toxicity following chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDP605

Epidemiology of sarcopenia among the elderly in New Mexico

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDP605

Total body skeletal muscle and adipose tissue volumes: estimation from a single abdominal cross-sectional image

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDP605

21 January 2018

Identifiers

DOI

10.1093/ANNONC/MDP605

1 reference

15 November 2017

1 reference